In his efforts to augment a bullpen that last year ranked last in the league in ERA, FIP and WHIP, Terry Ryan's moves essentially amounted to re-signing Matt Capps and adding Joel Zumaya to replace the departed Joe Nathan. That was hardly a recipe for guaranteed substantial improvement, and now with Zumaya's unfortunate yet unsurprising injury news, Ryan's passive approach to addressing this unit in a buyer's market looks all the more irresponsible. With their sole bullpen ...
Go to Profile
Mark as Read
